Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion type Assertion NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_head.
- NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion description "[We comparatively analyzed the expression of 6 selected anti-apoptotic genes, including survivin, in specimens from 30 dogs with histiocytic sarcoma and performed annexin V staining to evaluate apoptosis, methylthiazole tetrazolium assays to assess cell viability and chemosensitivity, and latex bead assays to measure changes in phagocytic activities in 4 CHS cell lines and normal canine fibroblasts transfected with survivin siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_provenance.
- NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion evidence source_evidence_literature NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_provenance.
- NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion SIO_000772 24260303 NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_provenance.
- NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion wasDerivedFrom befree-2016 NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_provenance.
- NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_assertion wasGeneratedBy ECO_0000203 NP1130169.RAYY29vu2hYLxQ4Hf47Y5Wpyzyy1H-NbifFu2ZRpN-XFk130_provenance.